The Future of GLP-1 & Metabolic Peptide Research The field of GLP-1 and metabolic peptides is rapidly evolving, with exciting developments on the horizon: 🔬 Triple agonists (GLP-1/GIP/glucagon) for enhanced weight loss and metabolic benefits 🧪 Oral formulations for improved patient compliance 💊 Combination therapies with SGLT2 inhibitors, insulin, or other agents 🧬 Personalized medicine approaches based on genetic and metabolic profiling 🧫 Novel delivery systems (microneedle patches, implantable devices)

